Wealth Science Advisors »

Alnylam Pharmaceuticals shares owned by Wealth Science Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Wealth Science Advisors from 13F filings

Historical chart of Wealth Science Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Wealth Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Wealth Science Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $158k 396 397.65

More positions owned by Wealth Science Advisors

Capital Group Growth Etf Shs Creation Uni (CGGR)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Equifax (EFX)
Apple (AAPL)
Amazon (AMZN)
Capital Group Equity Etf Tr Us Small And Mid (CGMM)
Eli Lilly & Co. (LLY)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)

View all positions for Wealth Science Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
American Century Companies

View all funds holding Alnylam Pharmaceuticals